In contrast, several studies suggest that inhibition of the Akt pathway in malignant melanoma and triple-negative breast cancer cells sensitizes them to ferroptosis induction by RSL3 (Li P. et al., 2022; Dunsche et al., 2023; Zeng et al., 2023). The gene discussed is AKT1; the disease is melanoma.